Marina Parry
@marinaparry.bsky.social
Senior Project Manager for prostate and kidney cancer National Clinical Audits. Ex-postdoc in cancer research (prostate and SMZL). Views all mine.
Reposted by Marina Parry
Fantastic opportunity from @turajliclab.bsky.social! 🚀
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
MI/25/63 Associate Scientist | Cancer Research UK Manchester Institute
We are seeking a highly motivated and accomplished Associate Scientist to help lead and shape the programme. You will act as an operational deputy to Professor Samra Turajlic, helping to bridge activi...
www.cruk.manchester.ac.uk
November 16, 2025 at 5:36 PM
Fantastic opportunity from @turajliclab.bsky.social! 🚀
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
Reposted by Marina Parry
So proud of my colleague Sacha Howell on this latest @nature.com publication reporting on the Breast Cancer-Anti-Progestin Prevention Study 1 (BC-APPS1) - many years in the making: www.nature.com/articles/s41...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
New study uncovers potential way to prevent breast cancer in pre-menopausal women
A University of Manchester study funded by Breast Cancer Now and supported by Prevent Breast Cancer, reveals a drug approved for use in other conditions could be repurposed to prevent breast cancer in...
www.manchester.ac.uk
November 6, 2025 at 10:04 AM
So proud of my colleague Sacha Howell on this latest @nature.com publication reporting on the Breast Cancer-Anti-Progestin Prevention Study 1 (BC-APPS1) - many years in the making: www.nature.com/articles/s41...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
Reposted by Marina Parry
The UK’s first one-stop kidney cancer clinic at @cuh.nhs.uk is transforming kidney cancer diagnosis. With a confocal microscope, patients can get a biopsy, diagnosis & treatment plan – all on the same day.
Find out more: crukcambridgecentre.org.uk/news/one-sto...
@crukcamurol.bsky.social
Find out more: crukcambridgecentre.org.uk/news/one-sto...
@crukcamurol.bsky.social
October 15, 2025 at 8:07 AM
The UK’s first one-stop kidney cancer clinic at @cuh.nhs.uk is transforming kidney cancer diagnosis. With a confocal microscope, patients can get a biopsy, diagnosis & treatment plan – all on the same day.
Find out more: crukcambridgecentre.org.uk/news/one-sto...
@crukcamurol.bsky.social
Find out more: crukcambridgecentre.org.uk/news/one-sto...
@crukcamurol.bsky.social
Reposted by Marina Parry
New CMO report out today on health trends and variation in England. My team delivered this using a RAP developed in R, which made a nice change from lots of people running around putting numbers into excel then pasting into powerpoint... Was not without challenges though! www.gov.uk/government/p...
Health trends and variation in England 2025: a Chief Medical Officer report
An overview of the health of England’s population, including trends over time and geographical variation.
www.gov.uk
September 25, 2025 at 10:23 AM
New CMO report out today on health trends and variation in England. My team delivered this using a RAP developed in R, which made a nice change from lots of people running around putting numbers into excel then pasting into powerpoint... Was not without challenges though! www.gov.uk/government/p...
Reposted by Marina Parry
1/2 With #WorldCancerResearchDay shining a light on cancer care, we update on the HQIP-commissioned National Cancer Audit Collaborating Centre, which hosts all ten #NHS national cancer audits that are part of the National Clinical Audit and Patient Outcomes Programme.
@natcan-news.bsky.social
@natcan-news.bsky.social
September 24, 2025 at 2:58 PM
1/2 With #WorldCancerResearchDay shining a light on cancer care, we update on the HQIP-commissioned National Cancer Audit Collaborating Centre, which hosts all ten #NHS national cancer audits that are part of the National Clinical Audit and Patient Outcomes Programme.
@natcan-news.bsky.social
@natcan-news.bsky.social
Reposted by Marina Parry
Our new website is live! 🎉
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
September 16, 2025 at 10:09 AM
Our new website is live! 🎉
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
ICYMI and want to know more about how tumor transcription-wide expression classifiers predict treatment sensitivity in advanced prostate cancers > look no further: www.cell.com/cell/pdf/S00...
September 9, 2025 at 7:37 AM
ICYMI and want to know more about how tumor transcription-wide expression classifiers predict treatment sensitivity in advanced prostate cancers > look no further: www.cell.com/cell/pdf/S00...
Reposted by Marina Parry
Could transcriptome signatures identify men with advanced #ProstateCancer most likely to benefit from chemotherapy?
A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social.
Grab a ☕ and read: doi.org/10.1016/j.ce...
A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social.
Grab a ☕ and read: doi.org/10.1016/j.ce...
September 2, 2025 at 4:15 PM
Could transcriptome signatures identify men with advanced #ProstateCancer most likely to benefit from chemotherapy?
A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social.
Grab a ☕ and read: doi.org/10.1016/j.ce...
A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social.
Grab a ☕ and read: doi.org/10.1016/j.ce...
Reposted by Marina Parry
A new test can identify which prostate cancer patients are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, shows a new study led by Prof Gert Attard & Dr Emily Grist @uclmedsci.bsky.social
www.ucl.ac.uk/news/2025/au...
www.ucl.ac.uk/news/2025/au...
Molecular test personalises prostate cancer treatment
Testing the molecular profile of tumours identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit f...
www.ucl.ac.uk
August 28, 2025 at 1:54 PM
A new test can identify which prostate cancer patients are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, shows a new study led by Prof Gert Attard & Dr Emily Grist @uclmedsci.bsky.social
www.ucl.ac.uk/news/2025/au...
www.ucl.ac.uk/news/2025/au...
REALLY thrilled to share findings from my postdoc work in the Attard lab, which form part of this www.sciencedirect.com/science/arti....
Thanks to Emily and Gert for seeing it over the line, all the funders, the Veracyte, MRC CTU & STAMPEDE teams, and patients who contributed samples. Pls share!
Thanks to Emily and Gert for seeing it over the line, all the funders, the Veracyte, MRC CTU & STAMPEDE teams, and patients who contributed samples. Pls share!
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
Advanced prostate cancers respond to hormone therapy but outcomes vary and no predictive tests exist for informed treatment selection. To identify nov…
www.sciencedirect.com
August 27, 2025 at 8:14 AM
REALLY thrilled to share findings from my postdoc work in the Attard lab, which form part of this www.sciencedirect.com/science/arti....
Thanks to Emily and Gert for seeing it over the line, all the funders, the Veracyte, MRC CTU & STAMPEDE teams, and patients who contributed samples. Pls share!
Thanks to Emily and Gert for seeing it over the line, all the funders, the Veracyte, MRC CTU & STAMPEDE teams, and patients who contributed samples. Pls share!
Reposted by Marina Parry
📢 Start your week with the latest National Prostate Cancer Audit study.
We found that the annual rate of metastatic prostate cancer at diagnosis was more than 60% higher in some regions than in others in England.
Paper link here 👉 bmjoncology.bmj.com/content/4/1/...
We found that the annual rate of metastatic prostate cancer at diagnosis was more than 60% higher in some regions than in others in England.
Paper link here 👉 bmjoncology.bmj.com/content/4/1/...
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation
Objective To evaluate the area-based incidence of metastatic prostate cancer at diagnosis, reflecting the risk of late-stage diagnosis, and overall prostate cancer incidence, reflecting the risk of ov...
bmjoncology.bmj.com
April 28, 2025 at 10:21 AM
📢 Start your week with the latest National Prostate Cancer Audit study.
We found that the annual rate of metastatic prostate cancer at diagnosis was more than 60% higher in some regions than in others in England.
Paper link here 👉 bmjoncology.bmj.com/content/4/1/...
We found that the annual rate of metastatic prostate cancer at diagnosis was more than 60% higher in some regions than in others in England.
Paper link here 👉 bmjoncology.bmj.com/content/4/1/...
Reposted by Marina Parry
NEW - Wellcome and UK Government partnering on a new health data research service, contributing up £600m together.
This will simplify secure access to health data and speed up research to better understand ill health.
wellcome.org/news/nationa...
This will simplify secure access to health data and speed up research to better understand ill health.
wellcome.org/news/nationa...
National data service will simplify access to health data for research | Wellcome
Wellcome is partnering with the UK Government to establish a £600 million health data research service. It will simplify secure access to health data for research.
wellcome.org
April 7, 2025 at 2:23 PM
NEW - Wellcome and UK Government partnering on a new health data research service, contributing up £600m together.
This will simplify secure access to health data and speed up research to better understand ill health.
wellcome.org/news/nationa...
This will simplify secure access to health data and speed up research to better understand ill health.
wellcome.org/news/nationa...
Reposted by Marina Parry
Excellent video about CAcTUS trial combining many aspects of #CancerResearch in #Manchester - including #immunotherapy, #melanoma research & #LiquidBiopsies - #ctDNA
Great to hear @beckilee.bsky.social - formerly of this parish - speak about her work, plus a moving account from patient Kathy Heaton
Great to hear @beckilee.bsky.social - formerly of this parish - speak about her work, plus a moving account from patient Kathy Heaton
🧬 Melanoma is the 5th most common cancer in the UK, but Manchester researchers are transforming treatment.
The CAcTUS clinical trial uses ctDNA to find the best time to switch between targeted therapy & immunotherapy for advanced melanoma.
🎥 Learn more: www.youtube.com/watch?v=6l6V...
The CAcTUS clinical trial uses ctDNA to find the best time to switch between targeted therapy & immunotherapy for advanced melanoma.
🎥 Learn more: www.youtube.com/watch?v=6l6V...
Melanoma research in Manchester - the CAcTUS clinical trial
YouTube video by Manchester Cancer Research Centre
www.youtube.com
April 2, 2025 at 12:23 PM
Excellent video about CAcTUS trial combining many aspects of #CancerResearch in #Manchester - including #immunotherapy, #melanoma research & #LiquidBiopsies - #ctDNA
Great to hear @beckilee.bsky.social - formerly of this parish - speak about her work, plus a moving account from patient Kathy Heaton
Great to hear @beckilee.bsky.social - formerly of this parish - speak about her work, plus a moving account from patient Kathy Heaton
What are the unique features, outputs and the future of NATCAN (National Cancer Audit Collaborating Centre, @natcan-news.bsky.social), where I manage the prostate @npca-natcan.bsky.social and kidney cancer audits @nkca-natcan.bsky.social?
The answers are here www.sciencedirect.com/science/arti...
The answers are here www.sciencedirect.com/science/arti...
April 1, 2025 at 3:51 PM
What are the unique features, outputs and the future of NATCAN (National Cancer Audit Collaborating Centre, @natcan-news.bsky.social), where I manage the prostate @npca-natcan.bsky.social and kidney cancer audits @nkca-natcan.bsky.social?
The answers are here www.sciencedirect.com/science/arti...
The answers are here www.sciencedirect.com/science/arti...
Reposted by Marina Parry
openRxiv has arrived!
We’re thrilled to announce the launch of openRxiv as an independent, researcher-led nonprofit to oversee bioRxiv and medRxiv, the world’s leading preprint servers for life and health sciences.
openrxiv.org/introducing-...
#openRxiv #OpenScience #Preprints #bioRxiv #medRxiv
We’re thrilled to announce the launch of openRxiv as an independent, researcher-led nonprofit to oversee bioRxiv and medRxiv, the world’s leading preprint servers for life and health sciences.
openrxiv.org/introducing-...
#openRxiv #OpenScience #Preprints #bioRxiv #medRxiv
March 11, 2025 at 1:18 PM
openRxiv has arrived!
We’re thrilled to announce the launch of openRxiv as an independent, researcher-led nonprofit to oversee bioRxiv and medRxiv, the world’s leading preprint servers for life and health sciences.
openrxiv.org/introducing-...
#openRxiv #OpenScience #Preprints #bioRxiv #medRxiv
We’re thrilled to announce the launch of openRxiv as an independent, researcher-led nonprofit to oversee bioRxiv and medRxiv, the world’s leading preprint servers for life and health sciences.
openrxiv.org/introducing-...
#openRxiv #OpenScience #Preprints #bioRxiv #medRxiv
⚠️Do you or someone you know want to come and work with me and the fantastic @npca-natcan.bsky.social @natcan-news.bsky.social teams based @collegeofsurgeons.bsky.social? Our oncological clinical lead is the super @alison-tree.bsky.social 😁.
Interested? Apply here www.jobs.ac.uk/job/DMB374/c...
Interested? Apply here www.jobs.ac.uk/job/DMB374/c...
March 11, 2025 at 9:13 AM
⚠️Do you or someone you know want to come and work with me and the fantastic @npca-natcan.bsky.social @natcan-news.bsky.social teams based @collegeofsurgeons.bsky.social? Our oncological clinical lead is the super @alison-tree.bsky.social 😁.
Interested? Apply here www.jobs.ac.uk/job/DMB374/c...
Interested? Apply here www.jobs.ac.uk/job/DMB374/c...
Reposted by Marina Parry
If you work in a hospital or a cancer alliance take some time to look at the data from the National Cancer Audit Collaborating Centre (NATCAN) Pancreatic Cancer Audit www.natcan.org.uk/reports/npac... It will help you to find the areas that you can identify for improvement #sethslegacy
NPaCA Quarterly Data Dashboard - National Cancer Audit Collaborating Centre
The purpose of the National Pancreatic Cancer Audit (NPaCA) is to evaluate the patterns of care and outcomes for patients with pancreatic cancer in England and Wales, and to support services to improv...
www.natcan.org.uk
March 8, 2025 at 8:51 AM
If you work in a hospital or a cancer alliance take some time to look at the data from the National Cancer Audit Collaborating Centre (NATCAN) Pancreatic Cancer Audit www.natcan.org.uk/reports/npac... It will help you to find the areas that you can identify for improvement #sethslegacy
Latest from Jo, Clinical Fellow in the NPCA.
Are mHSPC patients in England receiving treatment intensification? And are all sMDTs treating patients similarly?
Are mHSPC patients in England receiving treatment intensification? And are all sMDTs treating patients similarly?
📢 End your week with our hot off the press paper:
"Are Evidence-Based Guidelines Translating into Clinical Practice? A National Population-Based Study of the Use of Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in England"
www.ejcancer.com/article/S095...
"Are Evidence-Based Guidelines Translating into Clinical Practice? A National Population-Based Study of the Use of Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in England"
www.ejcancer.com/article/S095...
https://www.ejcancer.com/article/S0959-8049(25)00116-9/fulltext•
March 7, 2025 at 4:04 PM
Latest from Jo, Clinical Fellow in the NPCA.
Are mHSPC patients in England receiving treatment intensification? And are all sMDTs treating patients similarly?
Are mHSPC patients in England receiving treatment intensification? And are all sMDTs treating patients similarly?
Reposted by Marina Parry
We are finalists!! 🙌
Our #data team has been shortlisted for the #ACDM25 awards for designing an open-source database to integrate clinical and translational data in #ClinicalTrials.
Read the paper here - journals.sagepub.com/doi/10.1177/...
@cancerresearchuk.org @unisouthampton.bsky.social
Our #data team has been shortlisted for the #ACDM25 awards for designing an open-source database to integrate clinical and translational data in #ClinicalTrials.
Read the paper here - journals.sagepub.com/doi/10.1177/...
@cancerresearchuk.org @unisouthampton.bsky.social
February 19, 2025 at 9:23 AM
We are finalists!! 🙌
Our #data team has been shortlisted for the #ACDM25 awards for designing an open-source database to integrate clinical and translational data in #ClinicalTrials.
Read the paper here - journals.sagepub.com/doi/10.1177/...
@cancerresearchuk.org @unisouthampton.bsky.social
Our #data team has been shortlisted for the #ACDM25 awards for designing an open-source database to integrate clinical and translational data in #ClinicalTrials.
Read the paper here - journals.sagepub.com/doi/10.1177/...
@cancerresearchuk.org @unisouthampton.bsky.social
Reposted by Marina Parry
🚀 Our paper introducing ImmuneLENS, a new tool that measures T and B cell fractions from WGS data. This builds on our previous method, T cell ExTRECT, that used a signal from V(D)J recombination to measure T cells.
Out today in @naturegenet.bsky.social :
doi.org/10.1038/s41588-025-02086-5
🧵👇
Out today in @naturegenet.bsky.social :
doi.org/10.1038/s41588-025-02086-5
🧵👇
ImmuneLENS characterizes systemic immune dysregulation in aging and cancer - Nature Genetics
Immune lymphocyte estimation from nucleotide sequencing (ImmuneLENS) infers B cell and T cell fractions from whole-genome sequencing data. Applied to the 100,000 Genomes Project datasets, circulating ...
www.nature.com
February 18, 2025 at 3:24 PM
🚀 Our paper introducing ImmuneLENS, a new tool that measures T and B cell fractions from WGS data. This builds on our previous method, T cell ExTRECT, that used a signal from V(D)J recombination to measure T cells.
Out today in @naturegenet.bsky.social :
doi.org/10.1038/s41588-025-02086-5
🧵👇
Out today in @naturegenet.bsky.social :
doi.org/10.1038/s41588-025-02086-5
🧵👇
Reposted by Marina Parry
For the last 5 months, I’ve spoken to Rosy as she’s fought for care. MND means she needs a ventilator and feeding tube and yet she has been denied 24/7 carers. Rosy is now losing her voice but wants to speak out. We should all listen.
In today’s @theguardian.com www.theguardian.com/commentisfre...
In today’s @theguardian.com www.theguardian.com/commentisfre...
A reader with a terminal illness emailed in despair. What she told me should shock us all | Frances Ryan
Rosy is unable to move, breathe or eat unassisted. Yet for hours a day she is being left completely alone, says Guardian columnist Frances Ryan
www.theguardian.com
January 28, 2025 at 8:53 AM
For the last 5 months, I’ve spoken to Rosy as she’s fought for care. MND means she needs a ventilator and feeding tube and yet she has been denied 24/7 carers. Rosy is now losing her voice but wants to speak out. We should all listen.
In today’s @theguardian.com www.theguardian.com/commentisfre...
In today’s @theguardian.com www.theguardian.com/commentisfre...
Very proud to share the results of the NPCA team's hard work over the last few months.
It's a data rich report: increase in diagnoses and numbers of treatment, differences in diagnoses and treatments by age, ethnicity and deprivation.
Please share!
It's a data rich report: increase in diagnoses and numbers of treatment, differences in diagnoses and treatments by age, ethnicity and deprivation.
Please share!
The National Prostate Cancer Audit State of the Nation Report 2024 has been published! It is available here www.npca.org.uk/reports/npca... alongside its appendix, methodology supplement and data tables.
NPCA State of the Nation Report 2024 - National Prostate Cancer Audit
The aim of the National Prostate Cancer Audit (NPCA) is to evaluate the patterns of care and outcomes for patients with prostate cancer in England and Wales, and to support services to improve the qua...
www.npca.org.uk
January 9, 2025 at 4:52 PM
Very proud to share the results of the NPCA team's hard work over the last few months.
It's a data rich report: increase in diagnoses and numbers of treatment, differences in diagnoses and treatments by age, ethnicity and deprivation.
Please share!
It's a data rich report: increase in diagnoses and numbers of treatment, differences in diagnoses and treatments by age, ethnicity and deprivation.
Please share!
Reposted by Marina Parry
Throughout 2024, the Guardian aimed to report on every woman allegedly killed by a man. Here are the 80 women whose deaths have led to a man being charged. Let us say their names. www.theguardian.com/uk-news/ng-i...
Killed women count: 80 women allegedly killed by men in UK in 2024
Throughout the year the Guardian aimed to report on every woman whose death has led to a man being charged
www.theguardian.com
December 31, 2024 at 9:20 AM
Throughout 2024, the Guardian aimed to report on every woman allegedly killed by a man. Here are the 80 women whose deaths have led to a man being charged. Let us say their names. www.theguardian.com/uk-news/ng-i...
Reposted by Marina Parry
Even in the face of tragedy parents Merope and Paul fought to change the system and save other families from the same fate.
Martha’s rule having ‘transformative effect’, NHS England data shows
Martha’s rule having ‘transformative effect’, NHS England data shows
Mother of girl who died in 2013 reveals figures on Today programme that are welcomed by national medical director
Patients have been moved to intensive care or received potentially life-saving treatment such as oxygen as a direct result of hospitals…
www.theguardian.com
December 17, 2024 at 7:29 AM
Even in the face of tragedy parents Merope and Paul fought to change the system and save other families from the same fate.
Reposted by Marina Parry
There are now 24 step-by-step guides, explaining how to create these ⬇️ data visualizations with R/ggplot2 - I hope this is a useful resource. Find them all here: joachimgoedhart.github.io/DataViz-prot...
December 16, 2024 at 9:25 AM
There are now 24 step-by-step guides, explaining how to create these ⬇️ data visualizations with R/ggplot2 - I hope this is a useful resource. Find them all here: joachimgoedhart.github.io/DataViz-prot...